Indus Biotech Profile
Key Indicators
- Authorised Capital ₹ 43.00 Cr
- Paid Up Capital ₹ 15.77 Cr
- Company Age 29 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 12.97 Cr
- Satisfied Charges ₹ 22.02 Cr
- Revenue Growth 4.82%
- Profit Growth 128.44%
- Ebitda -2.81%
- Net Worth 268.82%
- Total Assets -24.32%
About Indus Biotech
Indus Biotech Limited (IBL) is a leading Public Limited Indian Non-Government Company incorporated in India on 16 February 1995 and has a history of 29 years and 11 months. Its registered office is in Pune, Maharashtra, India.
The Corporate was formerly known as Indus Biotech Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 43.00 Cr and a paid-up capital of Rs 15.77 Cr.
The company currently has active open charges totaling ₹12.97 Cr. The company has closed loans amounting to ₹22.02 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Indus Biotech Limited India are Achyut Huilgol as CFO and Rucha Khaire as Company Secretary.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24231MH1995PLC085656
-
Company No.
085656
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
16 Feb 1995
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Indus Biotech?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Achyut Huilgol
|
CFO | 14-Mar-2018 | Current |
|
Sunil Bhaskaran
|
Managing Director | 16-Feb-1995 | Current |
|
Rucha Khaire
|
Company Secretary | 19-Jun-2017 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Himanshu Nivsarkar
|
Nominee Director | 24-Mar-2017 | Current |
|
Anil Kumar
|
Director | 15-Nov-2021 | Current |
|
Rajan Srinivasan
|
Director | 01-Jan-2001 | Current |
|
Ranjeet Srinivasan
|
Director | 16-Feb-1995 | Current |
|
Shrikant Patil
|
Director | 15-Nov-2021 | Current |
Financial Performance of Indus Biotech.
Indus Biotech Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 4.82% increase. The company also saw a substantial improvement in profitability, with a 128.44% increase in profit. The company's net worth Soared by an impressive increase of 268.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indus Biotech?
In 2022, Indus Biotech had a promoter holding of 39.67% and a public holding of 60.33%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹12.97 Cr
₹22.02 Cr
Charges Breakdown by Lending Institutions
- Others : 12.04 Cr
- Vijaya Bank : 0.93 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jun 2021 | Others | ₹12.04 Cr | Open |
| 15 Jun 2017 | Vijaya Bank | ₹9.27 M | Open |
| 27 Oct 2015 | Others | ₹13.48 Cr | Satisfied |
| 15 Oct 2011 | Vijaya Bank | ₹5.20 M | Satisfied |
| 25 Aug 2009 | Vijaya Bank | ₹4.00 Cr | Satisfied |
How Many Employees Work at Indus Biotech?
Indus Biotech has a workforce of 138 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indus Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indus Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
